[1] The peptide won't surface to impact levels of insulin or IGF1 in studies thus far; thus, it doesn't seem to set off diabetes development or induce glucose intolerance in examination designs, nevertheless additional studies are needed to explore this element.[2]An Preliminary speculation proposed that AOD 9604 might bind and activate ?-3-adrener